Starting at $595 Sermorelin May help support metabolism, recovery, and body composition through natural growth hormone signaling
In 2024, the FDA expanded the label to include reducing the risk of major cardiovascular events in adults with established cardiovascular disease and overweight or obesity based on the SELECT trial, which randomized 17,604 patients and showed a 20% reduction in major adverse cardiovascular events over a mean 40 months
This dual action sets it apart, offering significant advantages over other weight loss medications by not only curbing appetite but also improving insulin sensitivity and enhancing metabolic functions
Is there any downtime or side effects with Weight Loss Solutions
doi: Gorgojo-Martnez JJ, Mezquita-Raya P, Carretero-Gmez J, et al